A systematic review of test performance in screening for oral cancer and precancer

Oral Oncology

Volumn 40, Issue 3, 2004, Pages 264-273

  Downer, Martin C ^a,b,d   Moles, David R ^a   Palmer, Stephen ^c   Speight, Paul M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Cancer; Oral; Precancer; Screening; Sensitivity; Specificity; Systematic review; Test

Indexed keywords

CANCER SCREENING; CELL HETEROGENEITY; DATA BASE; HUMAN; INFORMATION PROCESSING; LEUKOPLAKIA; MOUTH CANCER; MOUTH MUCOSA; POPULATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY CONTROL; RESEARCH; REVIEW; ROC CURVE; SOUTHEAST ASIA; STANDARD; TASK PERFORMANCE;

EID: 1642513333     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.08.013     Document Type: Article

References (53)

1. Banoczy J., Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 19:1991;265-267.
2. Barra S., Baron A.E., Barzan L., Caruso G., Veronesi A., Talamini R., et al Patients compliance in an early detection program for upper aero-digestive tract tumours in North-Eastern Italy. Soz Praventivmed. 35:1990;159-163.
3. Burzynski N.J., Firriolo F.J., Butters J.M., Sorrell C.L. Evaluation of oral cancer screening. J Cancer Educ. 12:1997;95-99.
4. Clayman G.L., Chamberlain R.M., Lee J.J., Lippman S.M., Hong W.K. Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial. J Cancer Educ. 10:1995;88-90.
5. Dombi C., Voros Balog T., Czegledy A., Hermann P., Vincze N., Banoczy J. Risk group assessment of oral precancer attached to X-ray lung-screening examinations. Community Dent Oral Epidemiol. 29:2001;9-13.
6. Downer M.C., Evans A.W., Hughes Hallett C.M., Jullien J.A., Speight P.M., Zakrzewska J.M. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol. 23:1995;84-88.
7. Downer M.C., Jullien J.A., Speight P.M. An interim determination of health gain from oral cancer and precancer screening: 2. developing a model of population screening. Community Dent Health. 14:1997;227-232.
8. Downer M.C., Jullien J.A., Speight P.M. An interim determination of health gain from oral cancer and precancer screening: 3. preselecting high risk individuals. Community Dent Health. 15:1998;72-76.
9. Eckert D., Bloom H.J., Ross L.S. A review of oral cancer screening and detection in the metropolitan Detroit cancer control program. Prog Clin Biol Res. 1982;83195-83206.
10. Eckert S.E., Goldstein G.R., Koka S. How to evaluate a diagnostic test. J Prosthet Dent. 83:2000;386-391.
11. Epstein J.B., Oakley C., Millner A., Emerton S., van der Meij E., Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:1997;537-547.
12. Field E.A., Morrison T., Darling A.E., Parr T.A., Zakrzewska J.M. Oral mucosal screening as an integral part of routine dental care. Br. Dent. J. 179:1995;262-266.
13. Garrote L.F., Sankaranarayanan R., Anta J.J.L., Salva A.R., Parkin D.M. An evaluation of the oral cancer control program in Cuba. Epidemiol. 6:1995;428-431.
14. Gupta P.C. Betel quid and oral cancer: prospects for prevention. O'Neill I.K., Chen J., Bartsch H. Relevance to human cancer of N-nitroso compounds, tobacco smoke and mycotoxins. IARC Sci Publ. 1991;466-470.
15. Hawkins R.J., Wang E.E.L., Leake J.L. Preventive health care, 1999 update: prevention of oral cancer mortality. J Can Dent Assoc. 65:1999;617.
16. Horowitz A.M., Goodman H.S., Yellowitz J.A., Nourjah P.A. The need for health promotion in oral cancer prevention and early detection. J Public Health Dent. 56:1996;319-330.
17. Ikeda N., Downer M.C., Ishii T., Fukano H., Nagao T., Inoue K. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dent Health. 12:1995;133-137.
18. Ikeda N., Downer M.C., Ozowa Y., Inoue C., Mizuno T., Kawai T. Characteristics of participants and non-participants in annual mass screening for oral cancer in 60-year-old residents of Tokoname city, Japan. Community Dent Health. 12:1995;83-88.
19. Ikeda N., Ishii T., Iida S., Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 19:1991;160-163.
20. Jovanovic A., Kostense P.J., Schulten E.A.J.M., Snow G.B., van der Waal I. Delay in diagnosis of oral squamous cell carcinoma; a report from The Netherlands. Eur J Cancer B Oral Oncol. 28b:1992;37-38.
21. Jullien J.A., Downer M.C., Speight P.M., Zakrzewska J.M. Evaluation of health care workers' accuracy in recognising oral cancer and pre-cancer. Int Dent J. 46:1996;334-339.
22. Jullien J.A., Downer M.C., Zakrzewska J.M., Speight P.M. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health. 12:1995;3-7.
23. Jullien J.A., Zakrzewska J.M., Downer M.C., Speight P.M. Attendance and compliance at an oral cancer screening programme in a general medical practice. Eur J Cancer B Oral Oncol. 31b:1995;202-206.
24. Lynch H.T., Pitakspraiwan P., Sombooncharoen S., Phanthumchinda P., Vechmon U., Srivanwat G.et al. A demonstration project on cancer screening in rural Thailand: preliminary report. Oncol. 42:1985;193-197.
25. Martin I.C., Kerawala C.J., Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 85:1998;444-446.
26. Mashberg A. Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III. Cancer. 46:1980;758-763.
27. Mashberg A. Tolonium (toluidine blue) rinse - a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV. J Am Med Assoc. 245:1981;2408-2410.
28. Mashberg A., Feldman L.J. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am. J. Surg. 156:1988;273-275.
29. Mathew B., Sankaranarayanan R., Sunilkumar K.B., Kuruvila B., Pisani P., Nair M.K. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer. 76:1997;390-394.
30. Mehta F.S., Gupta P.C., Bhonsle R.B., Murti P.R., Daftary D.K., Pindborg J.J. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev. 9:1986;219-225.
31. Nagao T., Ikeda N., Fukano H., Miyazaki H., Yano M., Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 36:2000;340-346.
32. Nagao T., Warnakulasuriya S., Ikeda N., Fukano H., Fujiwara K., Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen. 7:2000;203-208.
33. Onofre M.A., Sposto M.R., Navarro C.M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 91:2001;535-540.
34. Prout M.N. Early detection of head and neck cancer. Hosp Pract (Off Ed). 22:1987;111-112.
35. Rosenberg D., Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg. Oral Med. Oral Pathol. 67:1989;621-627.
36. Sankaranarayanan R., Mathew B., Jacob B.J., Thomas G., Somanathan T., Pisani P.et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. Cancer. 88:2000;664-673.
37. Seoane J., Gonzalez-Reforma N., Aguado A., Romero M.A., Varela-Centelles P.I. Assessment of dental students' diagnostic accuracy for oral cancer screening. J Dent Educ. 61:1997;437-439.
38. Seoane J., Varela-Centelles P.I., Gonzalez-Reforma N., Aguado A., Esparza G. Assessment of dental students' ability to recognise precancerous lesions and conditions. Eur J Dent Educ. 1:1997;172-175.
39. Silverman S., Migliorati C., Barbosa J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg. Oral Med. Oral Pathol. 57:1984;379-382.
40. Speight P.M., Elliott A.E., Jullien J.A., Downer M.C., Zakzrewska J.M. The use of artificial intelligence to identify people at risk of oral cancer and precancer. Br. Dent. J. 179:1995;382-387.
41. Warnakulasuriya K.A.S.S., Ekanayake A.N., Sivayoham S., Stjernsward J., Pindborg J.J., Sobin L.H.et al. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ. 62:1984;243-250.
42. Warnakulasuriya K.A.S.S., Johnson N.W. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J. Oral Pathol. Med. 25:1996;97-103.
43. Warnakulasuriya K.A.S.S., Nanayakkara B.G. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev. 15:1991;331-334.
44. Warnakulasuriya S., Ekanayake A., Stjernsward J., Pindborg J.J., Sivayoham S. Compliance following referral in the early detection of oral cancer and precancer in Sri Lanka. Community Dent Oral Epidemiol. 16:1988;326-329.
45. Warnakulasuriya S., Pindborg J.J. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health. 7:1990;73-79.
46. Wesley R.S., Kutty V.R., Matthew B., Sankaranarayanan R., Nair M.K. Economic comparison of two strategies of oral cancer screening. Health Policy Plann. 7:1992;284-289.
47. Westman E.C., Duffy M.B., Simel D.L. Should physicians screen for oral disease? A physical examination study of the oral cavity. J Gen Intern Med. 9:1994;558-562.
48. Undertaking systematic reviews of research on effectiveness. Report 4. 2001;University of York, York Publishing Services, York.
49. Gray M., Gold L., Burls A., Elley K. The effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice. West Midlands DES report. 2000;University of Birmingham, Birmingham.
50. Irwig L., Macaskill P., Glasziou P., Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol. 48:1995;119-130.
51. STATA version 6. 1999;Stata Corporation, Texas.
52. Moles D.R., Downer M.C., Speight P.M. Meta-analysis of measures of performance reported in oral cancer and precancer screening studies. Br. Dent. J. 192:2002;340-344.
53. Wilson J.M.G., Jungner G. Principles and practice of screening for disease. Public Health Papers No. 34. 1968;World Health Organization, Geneva.